Vincenzo Pavone

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage

Marco Ladetto, Federica De Marco, Fabio Benedetti et al. · Blood · 2008 · 253 citations · Full text

First-Line Treatment for Primary Testicular Diffuse Large B-Cell Lymphoma With Rituximab-CHOP, CNS Prophylaxis, and Contralateral Testis Irradiation: Final Results of an International Phase II Trial

Umberto Vitolo, Annalisa Chiappella, Andrés J.M. Ferreri et al. · Journal of Clinical Oncology · 2011 · 233 citations · Full text

Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Intergruppo Italiano Linfomi.

Massimo Federico, Umberto Vitolo, Pier Luigi Zinzani et al. · PubMed · 2000 · 184 citations

Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial

Umberto Vitolo, Annalisa Chiappella, Silvia Franceschetti et al. · The Lancet Oncology · 2014 · 182 citations

Hematological Malignancy, Lymphoid Neoplasia, Oncology +9

ABVD Versus Modified Stanford V Versus MOPPEBVCAD With Optional and Limited Radiotherapy in Intermediate- and Advanced-Stage Hodgkin's Lymphoma: Final Results of a Multicenter Randomized Trial by the Intergruppo Italiano Linfomi

Paolo G. Gobbi, Alessandro Levis, Teodoro Chisesi et al. · Journal of Clinical Oncology · 2005 · 172 citations · Full text